Why is Suven Life Scie. falling/rising?

As of 24-Jul, Suven Life Sciences Ltd is currently priced at 288.50, reflecting a slight increase of 0.5 (0.17%). The stock has demonstrated strong performance over the long term, with a remarkable 116.59% return over the past year and a staggering 669.33% increase over the last five years. However, despite these impressive figures, the company faces significant challenges, including operating losses and a weak long-term fundamental strength, as evidenced by a -49.94% annual growth rate in net sales and a -240.03% decline in operating profit over the last five years. Additionally, the company has reported negative results for the last three consecutive quarters, which may contribute to investor caution despite the recent uptick in delivery volume.
In the broader market context, Suven Life Sciences Ltd's short-term performance has been somewhat mixed, with a -1.06% return over the past week compared to a minor decline of -0.09% in the Sensex. While the stock has outperformed the benchmark in the long term, the recent decrease in institutional investor participation, which has fallen by -1.13%, raises concerns about the stock's stability and future growth potential. This decline in institutional interest, coupled with the company's negative EBITDA and weak ability to service debt, suggests that while the stock may be rising slightly in price, underlying fundamentals present a more cautious outlook.